These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38006254)

  • 1. Prognostic value of motor and extramotor involvement in ALS.
    Kabir V; Ombelet F; Hobin F; Lamaire N; De Vocht J; Van Damme P
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):67-74. PubMed ID: 38006254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic variability in ALS-FTD and effect on survival.
    Ahmed RM; Devenney EM; Strikwerda-Brown C; Hodges JR; Piguet O; Kiernan MC
    Neurology; 2020 May; 94(19):e2005-e2013. PubMed ID: 32277059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuum.
    Illán-Gala I; Montal V; Pegueroles J; Vilaplana E; Alcolea D; Dols-Icardo O; de Luna N; Turón-Sans J; Cortés-Vicente E; Martinez-Roman L; Sánchez-Saudinós MB; Subirana A; Videla L; Sala I; Barroeta I; Valldeneu S; Blesa R; Clarimón J; Lleó A; Fortea J; Rojas-García R
    Neurology; 2020 Nov; 95(18):e2565-e2576. PubMed ID: 32913016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral Sclerosis.
    Chiò A; Brunetti M; Barberis M; Iazzolino B; Montuschi A; Ilardi A; Cammarosano S; Canosa A; Moglia C; Calvo A
    JAMA Neurol; 2016 Apr; 73(4):425-30. PubMed ID: 26903389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis.
    Huynh W; Ahmed R; Mahoney CJ; Nguyen C; Tu S; Caga J; Loh P; Lin CS; Kiernan MC
    Expert Rev Neurother; 2020 Mar; 20(3):281-293. PubMed ID: 32031423
    [No Abstract]   [Full Text] [Related]  

  • 6. Motor neuron disease beginning with frontotemporal dementia: clinical features and progression.
    Gromicho M; Kuzma-Kozakiewicz M; Szacka K; Nieporecki K; Andersen PM; Grosskreutz J; Petri S; Pinto S; Uysal H; Swash M; De Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):508-516. PubMed ID: 34229542
    [No Abstract]   [Full Text] [Related]  

  • 7. [Genetic coherence between hereditary amyotrophic lateral sclerosis and frontotemporal dementia].
    Gjerde KV; Tysnes OB
    Tidsskr Nor Laegeforen; 2014 Feb; 134(3):302-6. PubMed ID: 24518478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and behavioural impairment in amyotrophic lateral sclerosis: A landmark of the disease? A mini review of longitudinal studies.
    Consonni M; Dalla Bella E; Bersano E; Lauria G
    Neurosci Lett; 2021 May; 754():135898. PubMed ID: 33862143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: Frequency of abnormality and effect on survival.
    Xu Z; Alruwaili ARS; Henderson RD; McCombe PA
    J Neurol Sci; 2017 May; 376():16-23. PubMed ID: 28431606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study.
    Pilotto A; Rossi F; Rinaldi F; Compostella S; Cosseddu M; Borroni B; Filosto M; Padovani A
    Neurodegener Dis; 2016; 16(5-6):411-6. PubMed ID: 27497596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognition and motor phenotypes in ALS: a retrospective study.
    Aiello EN; Pain D; Radici A; Aktipi KM; Sideri R; Appollonio I; Mora G
    Neurol Sci; 2022 Sep; 43(9):5397-5402. PubMed ID: 35608739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD).
    Zago S; Poletti B; Morelli C; Doretti A; Silani V
    Arch Ital Biol; 2011 Mar; 149(1):39-56. PubMed ID: 21412715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.
    Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC
    J Neurol; 2018 Aug; 265(8):1819-1828. PubMed ID: 29868980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Story of the ALS-FTD continuum retold: rather two distinct entities.
    Lulé DE; Aho-Özhan HEA; Vázquez C; Weiland U; Weishaupt JH; Otto M; Anderl-Straub S; Semler E; Uttner I; Ludolph AC
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):586-589. PubMed ID: 30257969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and behavioral status in Japanese ALS patients: a multicenter study.
    Watanabe Y; Raaphorst J; Izumi Y; Yoshino H; Ito S; Adachi T; Takigawa H; Masuda M; Atsuta N; Adachi Y; Isose S; Arai K; Yokota O; Oda M; Ogino M; Ichikawa H; Hasegawa K; Kimura H; Shimizu T; Aiba I; Yabe H; Kanba M; Kusumi K; Aoki T; Hiroe Y; Watanabe H; Nishiyama K; Nomoto M; Sobue G; Beeldman E; Hanajima R; Nakashima K;
    J Neurol; 2020 May; 267(5):1321-1330. PubMed ID: 31955246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis.
    Lillo P; Garcin B; Hornberger M; Bak TH; Hodges JR
    Arch Neurol; 2010 Jul; 67(7):826-30. PubMed ID: 20625088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phenotypic variability of amyotrophic lateral sclerosis.
    Swinnen B; Robberecht W
    Nat Rev Neurol; 2014 Nov; 10(11):661-70. PubMed ID: 25311585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALS.
    Raaphorst J; Beeldman E; Schmand B; Berkhout J; Linssen WH; van den Berg LH; Pijnenburg YA; Grupstra HF; Weikamp JG; Schelhaas HJ; Papma JM; van Swieten JC; de Visser M; de Haan RJ
    Neurology; 2012 Sep; 79(13):1377-83. PubMed ID: 22972650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Clinical Features and Outcomes in Motor Neuron Disease Associated with Behavioural Variant Frontotemporal Dementia.
    Cortés-Vicente E; Turon-Sans J; Gelpi E; Clarimón J; Borrego-Écija S; Dols-Icardo O; Illán-Gala I; Lleó A; Illa I; Blesa R; Al-Chalabi A; Rojas-García R
    Dement Geriatr Cogn Disord; 2018; 45(3-4):220-231. PubMed ID: 29886477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis.
    Falzone YM; Domi T; Mandelli A; Pozzi L; Schito P; Russo T; Barbieri A; Fazio R; Volontè MA; Magnani G; Del Carro U; Carrera P; Malaspina A; Agosta F; Quattrini A; Furlan R; Filippi M; Riva N
    Eur J Neurol; 2022 Jul; 29(7):1930-1939. PubMed ID: 35263489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.